The writing is on the wall for gender ideology and corporate America should respond. Its authorities are discredited, its sciences unfounded, and its public support dwindling — not to mention the very providers who push sex-denying procedures on minors are now being held accountable for the experiment they’ve been running.
Mount Sinai Health System is the latest example of this as they reach an agreement with the Department of Justice to stop providing sex-denying procedures on minors and provide free health care to those experiencing adverse side-effects of their experimentation.
DOJ began its investigation on the premise that the nonprofit hospital may have violated federal law regarding its sex-denying procedures on children. The nationwide probe follows the landmark HHS report that exposed WPATH perverse influences on providers, along with an insurance scheme that let hospitals to charge insurance, private and federally subsidized, for sex-denying procedures on minors that would typically not be covered.
Additionally, Mount Sinai agreed to dedicate $2 million to treating the adverse effects of sex-denying interventions, free of charge, to those who received them as minors. Keep in mind, sex-denying interventions are largely irreversible and carry side effects into adulthood, even for those who detransition. Detranstitioner Chloe Cole, who began puberty blockers at 13 and later a double mastectomy, now lives with conditions like chronic UTIs, chronic joint pain, and bone density issues, because of her “transition.”
This begs the question: why are corporations like Nike still covering these procedures for employees’ minor dependents through their health plans? With the help of 1792 Exchange, Bowyer Research, and ADF, Inspire Investing filed a shareholder proposal asking the company to evaluate the risks of backing groups like the Human Rights Campaign, which has pushed for such policies — risks to shareholder value, and, more importantly, to children.
The case for course correction only grows stronger as more hospitals, like Mount Sinai, back away from sex-denying interventions on minors, and companies, like Nike, absorb the market backlash from years of ideological distraction.
1792 Exchange has identified over 560 companies that currently fund the sex-denial of minors and has sent letters to each one sharing the reputational, legal, and financial risks of offering these procedures and associating with groups like the HRC. The goal being to lift companies out of darkness and into light, out of ideological capture and back into business.